{"id":"https://openalex.org/W4309974083","doi":"https://doi.org/10.37874/ms.v7i4.585","title":"ANALISIS EFEKTIVITAS BIAYA KOMBINASI CANDESARTAN-AMLODIPIN DENGAN CANDESARTAN-FUROSEMIDE PASIEN HIPERTENSI RAWAT INAP RS XXX","display_name":"ANALISIS EFEKTIVITAS BIAYA KOMBINASI CANDESARTAN-AMLODIPIN DENGAN CANDESARTAN-FUROSEMIDE PASIEN HIPERTENSI RAWAT INAP RS XXX","publication_year":2022,"publication_date":"2022-11-26","ids":{"openalex":"https://openalex.org/W4309974083","doi":"https://doi.org/10.37874/ms.v7i4.585"},"language":"id","primary_location":{"id":"doi:10.37874/ms.v7i4.585","doi":"https://doi.org/10.37874/ms.v7i4.585","is_oa":true,"landing_page_url":"https://doi.org/10.37874/ms.v7i4.585","pdf_url":"https://ojs.stfmuhammadiyahcirebon.ac.id/index.php/iojs/article/download/585/375","source":{"id":"https://openalex.org/S4210235397","display_name":"Medical Sains Jurnal Ilmiah Kefarmasian","issn_l":"2541-2027","issn":["2541-2027","2548-2114"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Sains : Jurnal Ilmiah Kefarmasian","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ojs.stfmuhammadiyahcirebon.ac.id/index.php/iojs/article/download/585/375","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056984546","display_name":"Nur Rahmi Hidayati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133793","display_name":"Universitas Muhammadiyah Cirebon","ror":"https://ror.org/045vhys49","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210133793"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Nur Rahmi Hidayati","raw_affiliation_strings":["Sekolah Tinggi Farmasi Muhammadiyah Cirebon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sekolah Tinggi Farmasi Muhammadiyah Cirebon","institution_ids":["https://openalex.org/I4210133793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068497523","display_name":"Rinto Susilo","orcid":"https://orcid.org/0000-0002-1228-3445","observed_orcids":["https://orcid.org/0000-0002-1228-3445"]},"institutions":[{"id":"https://openalex.org/I4210133793","display_name":"Universitas Muhammadiyah Cirebon","ror":"https://ror.org/045vhys49","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210133793"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Rinto Susilo","raw_affiliation_strings":["Sekolah Tinggi Farmasi Muhammadiyah Cirebon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sekolah Tinggi Farmasi Muhammadiyah Cirebon","institution_ids":["https://openalex.org/I4210133793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078313797","display_name":"Tomi Tomi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133793","display_name":"Universitas Muhammadiyah Cirebon","ror":"https://ror.org/045vhys49","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210133793"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Tomi","raw_affiliation_strings":["Sekolah Tinggi Farmasi Muhammadiyah Cirebon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sekolah Tinggi Farmasi Muhammadiyah Cirebon","institution_ids":["https://openalex.org/I4210133793"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086466183","display_name":"Sulistiorini Indriaty","orcid":"https://orcid.org/0000-0002-0695-3692","observed_orcids":["https://orcid.org/0000-0002-0695-3692"]},"institutions":[{"id":"https://openalex.org/I4210133793","display_name":"Universitas Muhammadiyah Cirebon","ror":"https://ror.org/045vhys49","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210133793"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Sulistiorini Indriaty","raw_affiliation_strings":["Sekolah Tinggi Farmasi Muhammadiyah Cirebon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sekolah Tinggi Farmasi Muhammadiyah Cirebon","institution_ids":["https://openalex.org/I4210133793"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035889501","display_name":"Dewi Kartika","orcid":"https://orcid.org/0000-0001-6528-5332","observed_orcids":["https://orcid.org/0000-0001-6528-5332"]},"institutions":[{"id":"https://openalex.org/I4210133793","display_name":"Universitas Muhammadiyah Cirebon","ror":"https://ror.org/045vhys49","country_code":"ID","type":"education","lineage":["https://openalex.org/I4210133793"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Dewi Kartika","raw_affiliation_strings":["Sekolah Tinggi Farmasi Muhammadiyah Cirebon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sekolah Tinggi Farmasi Muhammadiyah Cirebon","institution_ids":["https://openalex.org/I4210133793"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210133793"],"apc_list":null,"apc_paid":null,"fwci":0.1831,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.57969209,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"7","issue":"4","first_page":"951","last_page":"962"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7368000149726868,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.7368000149726868,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.23800000548362732,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hospitalization-costs","display_name":"hospital costs","score":0.6449999809265137},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.6940000057220459},{"id":"https://openalex.org/keywords/candesartan","display_name":"candesartan","score":0.8399999737739563},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":0.953000009059906},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.7279999852180481},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.949999988079071},{"id":"https://openalex.org/keywords/combination-antihypertensive-therapy","display_name":"combination antihypertensive therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/average-cost-effectiveness-ratio","display_name":"average cost-effectiveness ratio","score":0.8849999904632568},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.9990000128746033},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.7260000109672546},{"id":"https://openalex.org/keywords/bpjs-health-insurance","display_name":"BPJS health insurance","score":0.6449999809265137},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8796433210372925},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.6067362427711487},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.46673616766929626},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30835211277008057},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.03429725766181946},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.029485374689102173}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.37874/ms.v7i4.585","doi":"https://doi.org/10.37874/ms.v7i4.585","is_oa":true,"landing_page_url":"https://doi.org/10.37874/ms.v7i4.585","pdf_url":"https://ojs.stfmuhammadiyahcirebon.ac.id/index.php/iojs/article/download/585/375","source":{"id":"https://openalex.org/S4210235397","display_name":"Medical Sains Jurnal Ilmiah Kefarmasian","issn_l":"2541-2027","issn":["2541-2027","2548-2114"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Sains : Jurnal Ilmiah Kefarmasian","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.37874/ms.v7i4.585","doi":"https://doi.org/10.37874/ms.v7i4.585","is_oa":true,"landing_page_url":"https://doi.org/10.37874/ms.v7i4.585","pdf_url":"https://ojs.stfmuhammadiyahcirebon.ac.id/index.php/iojs/article/download/585/375","source":{"id":"https://openalex.org/S4210235397","display_name":"Medical Sains Jurnal Ilmiah Kefarmasian","issn_l":"2541-2027","issn":["2541-2027","2548-2114"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Sains : Jurnal Ilmiah Kefarmasian","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4309974083.pdf","grobid_xml":"https://content.openalex.org/works/W4309974083.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2851210226","https://openalex.org/W2899874113","https://openalex.org/W2946972961","https://openalex.org/W2947536527","https://openalex.org/W3009142711","https://openalex.org/W3161686480","https://openalex.org/W4205436175","https://openalex.org/W4210495509","https://openalex.org/W4252620118"],"related_works":["https://openalex.org/W7132233969","https://openalex.org/W3209925612","https://openalex.org/W3049184964","https://openalex.org/W3207964277","https://openalex.org/W3101567873","https://openalex.org/W2995171902","https://openalex.org/W2899096638","https://openalex.org/W4414401647","https://openalex.org/W4320159010","https://openalex.org/W4389257998"],"abstract_inverted_index":{"Hipertensi":[0],"merupakan":[1,76],"salah":[2],"satu":[3],"penyakit":[4],"degeneratif":[5],"yang":[6,85,91,106,134,189,222],"membutuhkan":[7],"perawatan":[8,39,154],"jangka":[9],"panjang,":[10],"sehingga":[11],"perlu":[12],"dilakukan":[13],"pengontrolan":[14],"pada":[15],"semua":[16],"pasien":[17,32,51,90,97,133,206,217],"hipertensi":[18,22,46,52,93,169,211],"agar":[19],"biaya":[20,49,220],"terapi":[21,194],"tersebut":[23],"dapat":[24],"efektif.":[25],"Penelitian":[26,74],"ini":[27,75],"bertujuan":[28],"untuk":[29],"mengetahui":[30],"karakteristik":[31,132],"(usia,":[33],"jenis":[34,43,166],"kelamin,":[35],"status":[36],"pembayaran,":[37],"lama":[38,153,160,228],"dan":[40,47,68,94,192],"tekanan":[41,148],"darah),":[42],"kombinasi":[44,157,167,174,197,214],"obat":[45,168],"efektivitas":[48,193,209],"pengobatan":[50],"di":[53,98],"Instalasi":[54,99],"Rawat":[55,100],"Inap":[56,101],"RS":[57,102],"XXX":[58,103],"Tahun":[59],"2021":[60,105],"berdasarkan":[61,131],"metode":[62],"Avarage":[63],"Cost":[64,70],"Effectiveness":[65,71],"Ratio":[66,72],"(ACER)":[67],"Incremental":[69],"(ICER).":[73],"penelitian":[77,130],"deskriptif":[78,122],"dengan":[79,127,212],"pengumpulan":[80],"data":[81],"secara":[82],"retrospektif.":[83],"Sampel":[84],"digunakan":[86,172],"adalah":[87],"rekam":[88],"medik":[89],"terdiagnosis":[92],"nota":[95],"pembayaran":[96],"tahun":[104,140],"memenuhi":[107],"kriteria":[108],"inklusi,":[109],"sebanyak":[110],"45.":[111],"Cara":[112],"pengambilan":[113],"sampel":[114],"menggunakan":[115,120,213],"total":[116],"sampling.":[117],"Analisis":[118],"hasil":[119],"analisis":[121],"dalam":[123],"bentuk":[124],"tabel":[125],"disertai":[126],"penjelasan.":[128],"Hasil":[129],"terbanyak":[135],"berusia":[136],"46":[137],"-":[138],"61":[139],"(44,44%),":[141],"perempuan":[142],"(51,11%),":[143],"BPJS":[144],"kelas":[145],"III":[146,151],"(66,67%),":[147],"darah":[149],"drajat":[150],"(33,33%),":[152],"lebih":[155],"singkat":[156],"Candesartan-Furosemide":[158,198,215],"rata-rata":[159],"rawat":[161,229],"inap":[162],"5,37":[163],"hari.":[164],"Berdasarkan":[165,201],"paling":[170,190],"banyak":[171],"yaitu":[173,176,196],"CCB+ARB":[175],"Amlodipin":[177],"tab":[178,183],"10":[179],"mg":[180,185],"+":[181],"Candesartan":[182],"16":[184],"(62,23%).":[186],"Nilai":[187,203],"ACER":[188],"cost-effective":[191],"tinggi":[195],"sebesar":[199,224],"Rp.42.113,58.":[200],"perhitungan":[202],"ICER":[204],"bila":[205],"menginginkan":[207],"peningkatan":[208],"penyembuhan":[210],"maka":[216],"harus":[218],"mengeluarkan":[219],"tambahan":[221],"dikeluarkan":[223],"Rp.14.712,05":[225],"per":[226],"hari":[227],"inap.":[230]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-11-30T00:00:00"}
